Andergechew Mulu of Armauer Hansen Research Institute in Ethiopia will develop an in-house HIV-1 drug resistance assay for Integrase Strand Transfer Inhibitors (INSTIs) that will be equivalent to the standard FDA-approved commercialized assays and available at low-cost for HIV care in Ethiopia.
Grant ID
GCET/01/0016
Show on Hub
On
Show on Spoke
Off
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
300000.00
Funding Currency
ETB
Exchange Rate (at time of payment)
0.0340000000
Funding Amount (in USD)
10200.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
10200.00
Co-Funded
False